Vicente Anido, Jr.
2013
In 2013, Vicente Anido, Jr. earned a total compensation of $8.2M as Chief Executive Officer & Chairman of the Board at Aerie Pharmaceuticals.
Compensation breakdown
| Bonus | $163,281 |
|---|---|
| Option Awards | $7,763,955 |
| Salary | $205,309 |
| Other | $40,000 |
| Total | $8,172,545 |
Anido received $7.8M in option awards, accounting for 95% of the total pay in 2013.
Anido also received $163.3K in bonus, $205.3K in salary and $40K in other compensation.
Rankings
In 2013, Vicente Anido, Jr.'s compensation ranked 600th out of 12,286 executives tracked by ExecPay. In other words, Anido earned more than 95.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 600 out of 12,286 | 95th |
Division Manufacturing | 189 out of 4,612 | 96th |
Major group Chemicals And Allied Products | 48 out of 1,462 | 97th |
Industry group Drugs | 30 out of 1,156 | 97th |
Industry Biological Products, Except Diagnostic Substances | 3 out of 196 | 99th |
Source: SEC filing on February 27, 2015.
Anido's colleagues
We found four more compensation records of executives who worked with Vicente Anido, Jr. at Aerie Pharmaceuticals in 2013.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019